TASHKENT, Uzbekistan, November 22. Uzbekistan
and China have discussed joint initiatives aimed at strengthening
cooperation in the pharmaceutical sector, expanding local
production, and developing investment projects, Trend reports via the Agency
for the Development of the Pharmaceutical Industry of
Uzbekistan.
The parties explored opportunities to increase the turnover of
pharmaceutical products and raw materials as part of efforts to
deepen industry-level collaboration.
The discussions took place during a meeting between
representatives of the Agency for the Development of the
Pharmaceutical Industry and a delegation from the Xinjiang
Pharmaceutical Administration of the People’s Republic of China,
led by its Director General, Sui Yang.
Both sides expressed readiness to continue cooperation and
further develop an active dialogue to implement the agreed
initiatives.
Founded in 2017, the Agency for the Development of the
Pharmaceutical Industry (Pharm Agency) is a government institution
in Uzbekistan tasked with enhancing the nation’s pharmaceutical
industry. Its primary objectives encompass formulating and
executing strategies to promote industry growth, enhancing the
accessibility of affordable, high-quality pharmaceuticals and
medical products, and overseeing their production, importation, and
distribution.
Meanwhile, bilateral trade turnover between the two countries
exceeded $14 billion last year, and since the beginning of 2025, it
has grown by 23 percent. This steady upward trend underscores the
strengthening of economic ties and reaffirms China’s role as one of
Uzbekistan’s key and reliable partners.
Stay up-to-date with more news on Trend News
Agency’s WhatsApp channel
